FDA Approved: BROMFENAC OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for Bromfenac Ophthalmic Solution (bromfenac sodium) from Bausch & Lomb Americas Inc. to support use for postoperative pain and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation Following Cataract Surgery
• Postoperative Ocular Pain

Drugs mentioned

• Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

SUPPL AP for BROMFENAC OPHTHALMIC SOLUTION (BROMFENAC SODIUM)